Development and attestation of a standard sample of calcium nadroparin
Introduction. The widespread use of heparin preparations for the treatment and prevention of venous thromboembolic complications is known. One of the low molecular weight heparin drugs successfully used in clinical practice is calcium nadroparin. The modern approach to assessing the quality of medic...
Saved in:
| Main Authors: | A. V. Zykova, S. V. Krivoshchekov, D. A. Isakov, A. M. Guryev, M. V. Belousov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2024-06-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/1836 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Opportunities of using nadroparin calcium for prevention thrombotic complications at risk of coagulopathic bleeding
by: T. A. Sushko, et al.
Published: (2024-01-01) -
Determination of factor Xa inhibition doses of low-molecular heparin, nadroparin and reviparin in urological patients
by: Pavlović Svetlana, et al.
Published: (2007-01-01) -
Recurrent failure of ART, thrombosis and thrombophilia
by: J. Kh. Khizroeva, et al.
Published: (2024-01-01) -
Comparative laboratory effectiveness of low molecular weight heparins in patients with acute coronary syndrome and no ST segment elevation
by: R. M. Linchak, et al.
Published: (2011-02-01) -
The reduction of the standard of census route length using double lamination of sample
by: V. M. Glushkov
Published: (2018-04-01)